olivLaw · European equity research
Nextensa NEXTA.BR
Belgium · Euronext Brussels · Vertical: Listed companies from Belgium
At the close of 02 Nov 2026, Nextensa (NEXTA.BR) stock was 46.00 EUR (+0.65% on the day), with beta 0.27, 52-week range 40.20–48.90 EUR.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 58.4
- strong (55–70)
- Bollinger (20, 2)
- 42.99 – 47.13
- in the upper half of the band · %B 0.73 · band width 9.2%
- SMA 50 / 200
- 45.46 / 45.68
- mixed trend
- MACD (12, 26, 9)
- 0.30 / 0.16
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | +5.5% | −1.0% | +6.5 pp | — |
| 3 months | +3.1% | −3.9% | +7.0 pp | — |
| 6 months | −2.1% | +7.2% | −9.3 pp | — |
| Year to date | +7.7% | +6.6% | +1.2 pp | — |
| 1 year | +13.0% | +9.1% | +3.9 pp | +5.6% |
| 3 years | −2.2% | +47.9% | −50.2 pp | −4.3% |
| 5 years | −39.4% | +43.3% | −82.7 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
EPS unavailable in the issuer's structured filings (e.g. a partnership reports per unit, not per share).
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | unavailable | unavailable | unavailable |
| Revenue YoY | unavailable | unavailable | unavailable |
| Net income | 71.3 m | 24.5 m | -10.8 m |
| Net income YoY | unavailable | −65.7% | −144.2% |
| Diluted EPS | unavailable | unavailable | unavailable |
| Diluted EPS YoY | unavailable | unavailable | unavailable |
| net % | unavailable | unavailable | unavailable |
| Free cash flow | unavailable | unavailable | unavailable |
Balance sheet & financial health
Fiscal year 2024 · 31 Dec 2024
- Cash
- 8.6 m EUR
- Financial debt
- unavailable EUR
- Net debt
- unavailable EUR
- Equity
- 812.1 m EUR
- Total assets
- 1.7 bn EUR
- Debt / equity
- unavailable
- Current ratio
- 1.10x
- ROE
- -1.3%
- ROA
- -0.6%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (EUR)
Income statement · EUR
Balance sheet · EUR
| Line | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|
| Cash | 31.1 m | 11.1 m | 8.6 m | esef· 15 Apr 2025verified |
| Inventories | 98.3 m | 102.1 m | 108.9 m | esef· 15 Apr 2025verified |
| Current assets | 296.7 m | 295.2 m | 447.1 m | esef· 15 Apr 2025verified |
| Intangibles (excl. goodwill) | 855.0 k | 624.0 k | 378.0 k | esef· 15 Apr 2025verified |
| Total assets | 1.8 bn | 1.8 bn | 1.7 bn | esef· 15 Apr 2025verified |
| Current liabilities | 225.4 m | 318.2 m | 407.0 m | esef· 15 Apr 2025verified |
| Total liabilities | 918.9 m | 936.8 m | 887.8 m | esef· 15 Apr 2025verified |
| Equity | 849.5 m | 844.5 m | 812.1 m | esef· 15 Apr 2025verified |
Cash flow · EUR
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- indicators available: 2 of at least 6
- score weight coverage: 10.4% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
02 Nov 2026Source: olivLaw, closing series
Market cap: unavailable
Key indicators
Coverage and freshness
The data is older than the freshness threshold.
Score by group
10% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/Eunavailable · input data missing
- Dividend discount (DDM)unavailable · input data missing
no valuation method could be computed
Assumptions (illustrative, editorial)
- Risk-free rate
- 3.0%
- Equity risk premium
- 5.5%
- Beta (default)
- 1.00
- Cost of equity
- 8.5%
- Terminal growth
- 2.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 2 of at least 6; score weight coverage: 10.4% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | unavailable | unavailable | — |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 0.5x | 0 (on a fixed band) | 60% |
| Current ratio · Balance sheet | 1.1x | 25 (on a fixed band) | 40% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet10/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality· partialunavailable · 0/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
NEXTENSA (NEXTA.BR). Latest full fiscal year: 2024; data up to 2024-12-31.
Figures computed from the financial statements: ROE -1.3%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (indicators available: 2 of at least 6; score weight coverage: 10.4% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
What contradicts it
- Interest coverage: 0.5x
- Current ratio: 1.1x
Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Listed companies from Belgium · same country · compared with 40 companies
Multiples and returns vs the median
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ELI.BRElia Group | 11.6 bn | 22.7 | 9.6% | 13.6% | −2.0% | +25% / +31% |
| LOTB.BRLotus Bakeries | 11.2 bn | 64.8 | 20.9% | 12.7% | +10.0% | +78% / +72% |
| GBLB.BRGroupe Bruxelles Lambert - Groep Brussel Lambert | 10.4 bn | 81.4 | 0.8% | 2.1% | +1.0% | +5% / +7% |
| DIE.BRD'ieteren Group | 9.5 bn | 22.6 | — | 5.3% | −1.5% | +18% / +13% |
| ACKB.BRAckermans & Van Haaren | 8.9 bn | 22.2 | 8.4% | 7.6% | +18.6% | +22% / +78% |
| DEME.BRDeme Group | 4.3 bn | 12.3 | 15.5% | 8.3% | +1.3% | +22% / +74% |
| COLR.BRColruyt Group | 4.2 bn | 13.8 | 9.4% | 2.9% | +3.1% | +6% / −11% |
| AZE.BRAzelis Group | 2.9 bn | 16.0 | 6.6% | 4.3% | +1.5% | +28% / −42% |
| MELE.BRMelexis | 2.3 bn | 13.2 | 30.7% | 18.4% | −3.3% | +5% / −34% |
| BEKB.BRNV Bekaert SA | 2.1 bn | 30.8 | 3.1% | 1.8% | −6.4% | +11% / −4% |
| FAGR.BRFagron | 1.7 bn | 21.4 | 16.7% | 9.2% | +14.3% | +11% / +36% |
| KIN.BRKinepolis Group | 1.3 bn | 32.8 | 19.3% | 7.0% | −4.5% | +56% / +8% |
| JEN.BRJensen Group | 697.3 m | 16.9 | 15.1% | 9.1% | +13.3% | +26% / +108% |
| BAR.BRBarco | 574.6 m | 9.3 | 7.9% | 6.7% | −9.9% | −47% / −58% |
| IBAB.BRIon Beam Applications | 473.1 m | 38.4 | 10.7% | 2.1% | +24.5% | +43% / +48% |
| DECB.BRDeceuninck | 333.6 m | 24.0 | 4.3% | 1.7% | −4.5% | +6% / +6% |
| MOUR.BRMoury Construct | 262.0 m | 10.7 | 21.3% | 13.1% | −4.0% | +11% / +77% |
| CFEB.BRAannemingsmaatschappij Cfe | 261.9 m | 10.9 | 9.9% | 2.0% | −5.3% | +20% / +45% |
| CAMB.BRCampine | 258.0 m | 11.6 | 28.6% | 6.1% | +13.4% | −17% / +147% |
| EVS.BREvs Broadcast Equipment | 237.0 m | 5.8 | 20.8% | 21.7% | +14.3% | −50% / −38% |
| BPOST.BRBpost | 225.0 m | 3.4 | 6.3% | 1.5% | −2.6% | −41% / −75% |
| ECONB.BREconocom Group | 197.3 m | 37.9 | 1.2% | 0.2% | +4.3% | −7% / −40% |
| MONNI.BRKeyware Technologies | 180.0 m | 170.6 | 3.5% | 4.5% | −5.9% | 0% / −13% |
| IMMO.BRImmobel | 177.6 m | — | -7.4% | -25.2% | −32.8% | −22% / −34% |
| HYSG.BRHybrid Software Group PLC | 118.1 m | — | -2.5% | -5.5% | +7.2% | −6% / +10% |
1- and 3-year price returns: for NEXTA.BR from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202415 Apr 2025
- Annual report 202302 Apr 2024
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.